Literature DB >> 21303453

Breed differences in the proportional morbidity of testicular tumours and distribution of histopathologic types in a population-based canine cancer registry.

A Nødtvedt1, H Gamlem, G Gunnes, T Grotmol, A Indrebø, L Moe.   

Abstract

Histologically verified tumours submitted to the Norwegian Canine Cancer Register from 1990 to 1998 were studied (n=14,401). The proportion of testicular tumours (n=345) was 2.4%, and the breakdown of histological tumour diagnoses is presented. The frequency of the most common histopathological types was 33% interstitial (Leydig), 26.4% Sertoli and 33.9% seminomas/germ cell tumours. The average age at diagnosis was 10 years, but was significantly lower for Sertoli cell tumours (8.6 years) than for the other tumour types. Following a histopathological re-evaluation, 22.5% of the original tumor diagnoses were modified. Proportional morbidity ratios were calculated and individuals from the breeds Shetland sheepdog and Collie were five times more likely to have testicular tumours than the overall average for the registry. Breed differences in the distribution of histopathologic types were observed. Shetland sheepdog and Collie were most commonly diagnosed with Sertoli cell tumours, while all tumours from Norwegian elkhound in this material were seminomas.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 21303453     DOI: 10.1111/j.1476-5829.2010.00231.x

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  13 in total

1.  Estrogen-induced myelotoxicity in a 4-year-old golden retriever dog due to a Sertoli cell tumor.

Authors:  Hayden Marshall
Journal:  Can Vet J       Date:  2018-04       Impact factor: 1.008

2.  Sertoli cell tumor/mixed germ cell-stromal cell tumor as separate neoplasms in a bilaterally cryptorchid dog.

Authors:  Teagan L DeForge
Journal:  Can Vet J       Date:  2020-09       Impact factor: 1.008

3.  Anti-Müllerian hormone: a potentially useful biomarker for the diagnosis of canine Sertoli cell tumours.

Authors:  Bodil S Holst; Ulrika Dreimanis
Journal:  BMC Vet Res       Date:  2015-07-25       Impact factor: 2.741

4.  Estimated incidence rate and distribution of tumours in 4,653 cases of archival submissions derived from the Dutch golden retriever population.

Authors:  Kim M Boerkamp; Erik Teske; Lonneke R Boon; Guy C M Grinwis; Lindsay van den Bossche; Gerard R Rutteman
Journal:  BMC Vet Res       Date:  2014-01-31       Impact factor: 2.741

5.  Canine tumor development and crude incidence of tumors by breed based on domestic dogs in Gifu prefecture.

Authors:  Satoshi Komazawa; Hiroki Sakai; Yusuke Itoh; Mifumi Kawabe; Mami Murakami; Takashi Mori; Kohji Maruo
Journal:  J Vet Med Sci       Date:  2016-05-06       Impact factor: 1.267

6.  Estimating canine cancer incidence: findings from a population-based tumour registry in northwestern Italy.

Authors:  Elisa Baioni; Eugenio Scanziani; Maria Claudia Vincenti; Mauro Leschiera; Elena Bozzetta; Marzia Pezzolato; Rosanna Desiato; Silvia Bertolini; Cristiana Maurella; Giuseppe Ru
Journal:  BMC Vet Res       Date:  2017-06-28       Impact factor: 2.741

7.  Breed-predispositions to cancer in pedigree dogs.

Authors:  Jane M Dobson
Journal:  ISRN Vet Sci       Date:  2013-01-17

8.  Breed predisposition to canine gastric carcinoma--a study based on the Norwegian canine cancer register.

Authors:  Tonje Seim-Wikse; Einar Jörundsson; Ane Nødtvedt; Tom Grotmol; Charlotte R Bjornvad; Annemarie T Kristensen; Ellen Skancke
Journal:  Acta Vet Scand       Date:  2013-03-21       Impact factor: 1.695

9.  Morphological and immunohistochemical characterisation of seminomas in Norwegian dogs.

Authors:  Tor Espen Thorvaldsen; Ane Nødtvedt; Tom Grotmol; Gjermund Gunnes
Journal:  Acta Vet Scand       Date:  2012-09-17       Impact factor: 1.695

10.  Canine testicular tumors: two types of seminomas can be differentiated by immunohistochemistry.

Authors:  Marko Hohšteter; Branka Artuković; Krešimir Severin; Andrea Gudan Kurilj; Ana Beck; Ivan-Conrado Šoštarić-Zuckermann; Željko Grabarević
Journal:  BMC Vet Res       Date:  2014-08-06       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.